Sensitivity analyses to account for losses to follow-up in the antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial

被引：0
|
作者：
Davis, BR [1 ]
Ford, C [1 ]
Pressel, S [1 ]
Dunn, K [1 ]
Piller, L [1 ]
机构：
[1] Univ Texas, Sch Publ Hlth, Houston, TX USA
来源：
CONTROLLED CLINICAL TRIALS | 2003年 / 24卷
关键词：
D O I：
暂无
中图分类号：
R-3 [医学研究方法]; R3 [基础医学];
学科分类号：
1001 ;
摘要：
68
引用
收藏
页码：76S / 76S
页数：1
相关论文
共 50 条
  • [31] Metabolic issues in the antihypertensive and lipid-lowering heart attack trial study
    Punzi, HA
    Punzi, CE
    CURRENT HYPERTENSION REPORTS, 2004, 6 (02) : 106 - 110
  • [32] Metabolic issues in the antihypertensive and lipid-lowering heart attack trial study
    Henry A. Punzi
    Connie F. Punzi
    Current Hypertension Reports, 2004, 6 : 106 - 110
  • [33] Impact of the antihypertensive and lipid-lowering treatment to prevent heart attack trial (ALLHAT) on physician prescribing patterns and patient utilization of antihypertensive medications
    Liu, X
    Yu, W
    Yokoyama, K
    VALUE IN HEALTH, 2004, 7 (03) : 334 - 334
  • [34] Rationale and design for the antihypertensive and lipid lowering treatment to prevent heart attack trial (ALLHAT)
    Davis, BR
    Cutler, JA
    Gordon, DJ
    Furberg, CD
    Wright, JT
    Cushman, WC
    Grimm, RH
    LaRosa, J
    Whelton, PK
    Perry, HM
    Alderman, MH
    Ford, CE
    Oparil, S
    Francis, C
    Proschan, M
    Pressel, S
    Black, HR
    Hawkins, CM
    AMERICAN JOURNAL OF HYPERTENSION, 1996, 9 (04) : 342 - 360
  • [35] The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT): ALL predictable, and no big surprise out of a HAT?
    D G Beevers
    K W Lee
    G Y H Lip
    Journal of Human Hypertension, 2003, 17 : 367 - 372
  • [36] The antihypertensive and lipid-lowering treatment to prevent heart attack trial (ALLHAT): ALL predictable, and no big surprise out of a HAT?
    Beevers, DG
    Lee, KW
    Lip, GYH
    JOURNAL OF HUMAN HYPERTENSION, 2003, 17 (06) : 367 - 372
  • [37] Clinical outcomes in participants with cardiovascular dysmetabolic syndrome in the antihypertensive and lipid-lowering treatment to prevent heart attack trial (ALLHAT)
    Black, H
    Davis, B
    JOURNAL OF HYPERTENSION, 2005, 23 : S146 - S146
  • [38] Baseline Quality of Life and Risk of Stroke in the ALLHAT Study (Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial)
    Shams, Tanzila
    Auchus, Alexander P.
    Oparil, Suzanne
    Wright, Clinton B.
    Wright, Jackson
    Furlan, Anthony J.
    Sila, Cathy A.
    Davis, Barry R.
    Pressel, Sara
    Yamal, Jose-Miguel
    Einhorn, Paula T.
    Lerner, Alan J.
    STROKE, 2017, 48 (11) : 3078 - +
  • [39] Antihypertensive treatments in obese patients: the Antihypertensive and Lipid Lowering Treatment to Prevent Heart Attack Trial experience
    Jordan, Jens
    Engeli, Stefan
    JOURNAL OF HYPERTENSION, 2014, 32 (07) : 1402 - 1404
  • [40] Should Antihypertensive Treatment Recommendations Differ in Patients With and Without Coronary Heart Disease? (from the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial [ALLHAT])
    Alderman, Michael H.
    Davis, Barry R.
    Piller, Linda B.
    Ford, Charles E.
    Baraniuk, M. Sarah
    Pressel, Sara L.
    Assadi, Mahshid A.
    Einhorn, Paula T.
    Haywood, L. Julian
    Ilamathi, Ekambaram
    Oparil, Suzanne
    Retta, Tamrat M.
    AMERICAN JOURNAL OF CARDIOLOGY, 2016, 117 (01): : 105 - 115
12345